• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗后的长期心脏逆向重构

Long-term cardiac reverse remodeling after cardiac resynchronization therapy.

作者信息

Alvarez-Alvarez Belén, García-Seara Javier, Martínez-Sande Jose L, Rodríguez-Mañero Moisés, Fernández López Xesús A, González-Melchor Laila, Iglesias-Alvarez Diego, Gude Francisco, Díaz-Louzao Carla, González-Juanatey José R

机构信息

Cardiology Department Clinical University Hospital of Santiago de Compostela Santiago de Compostela Spain.

Arrhythmia Unit Clinical University Hospital of Santiago de Compostela Santiago de Compostela Spain.

出版信息

J Arrhythm. 2021 Mar 21;37(3):653-659. doi: 10.1002/joa3.12527. eCollection 2021 Jun.

DOI:10.1002/joa3.12527
PMID:34141018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8207409/
Abstract

INTRODUCTION

The benefit of cardiac resynchronization therapy (CRT) in heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) have been observed in the first year. However, there are few data on long-term follow-up and the effect of changes of LVEF on mortality. This study aimed to assess the LV remodeling after CRT implantation and the probable effect of changes in LVEF with repeated measures on mortality over time in a real-world registry.

METHODS

Among our cohort of 328 consecutive CRT patients, mixed model effect analysis have been made to describe the temporal evolution of LVEF and LVESV changes over time up with several explanatory variables. Besides, the effect of LVEF along time on the probability of mortality was evaluated using joint modeling for longitudinal and survival data.

RESULTS

The study population included 328 patients (253 men; 70.2 ± 9.5 years) in 4.2 (2.9) years follow-up. There was an increase in LVEF of 11% and a reduction in LVESV of 42 mL during the first year. These changes are more important during the first year, but slight changes remain during the follow-up. The largest reduction in LVESV occurred in patients with left bundle branch block (LBBB) and the smallest reduction in patients with NYHA IV. The smallest increase in LVEF was an ischemic etiology, longer QRS, and LV electrode in a nonlateral vein. Besides, the results showed that the LVEF profiles taken during follow-up after CRT were associated with changes in the risk of death.

CONCLUSION

Reverse remodeling of the left ventricle is observed especially during the first year, but it seems to be maintained later after CRT implantation in a contemporary cohort of patients. Longitudinal measurements could give us additional information at predicting the individual mortality risk after adjusting by age and sex compared to a single LVEF measurement after CRT.

摘要

引言

心脏再同步治疗(CRT)对左心室射血分数(LVEF)降低的心力衰竭(HF)患者的益处已在第一年得到观察。然而,关于长期随访以及LVEF变化对死亡率影响的数据较少。本研究旨在评估CRT植入后的左心室重构以及LVEF变化与重复测量对现实世界注册研究中随时间推移死亡率的可能影响。

方法

在我们连续的328例CRT患者队列中,采用混合模型效应分析来描述LVEF和左心室收缩末期容积(LVESV)随时间的变化以及几个解释变量。此外,使用纵向和生存数据的联合模型评估LVEF随时间对死亡概率的影响。

结果

研究人群包括328例患者(253例男性;年龄70.2±9.5岁),随访4.2(2.9)年。第一年LVEF增加11%,LVESV减少42 mL。这些变化在第一年更为显著,但随访期间仍有轻微变化。LVESV减少最大的发生在左束支传导阻滞(LBBB)患者中,NYHA IV级患者减少最小。LVEF增加最小的是缺血性病因、QRS波较长以及左心室电极位于非侧支静脉的患者。此外,结果表明CRT术后随访期间的LVEF变化与死亡风险变化相关。

结论

尤其是在第一年观察到左心室逆向重构,但在当代患者队列中CRT植入后似乎后期仍能维持。与CRT术后单次LVEF测量相比,纵向测量在按年龄和性别调整后预测个体死亡风险时能为我们提供更多信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/8207409/8ec6c9f225c1/JOA3-37-653-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/8207409/b237ffe91630/JOA3-37-653-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/8207409/babe8503c7d8/JOA3-37-653-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/8207409/8ec6c9f225c1/JOA3-37-653-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/8207409/b237ffe91630/JOA3-37-653-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/8207409/babe8503c7d8/JOA3-37-653-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/8207409/8ec6c9f225c1/JOA3-37-653-g001.jpg

相似文献

1
Long-term cardiac reverse remodeling after cardiac resynchronization therapy.心脏再同步治疗后的长期心脏逆向重构
J Arrhythm. 2021 Mar 21;37(3):653-659. doi: 10.1002/joa3.12527. eCollection 2021 Jun.
2
Left Ventricular Reverse Remodeling in Cardiac Resynchronization Therapy and Long-Term Outcomes.左心室逆向重构在心脏再同步治疗和长期预后中的作用。
JACC Clin Electrophysiol. 2019 Sep;5(9):1001-1010. doi: 10.1016/j.jacep.2019.07.012.
3
Long-term outcomes of cardiac resynchronization therapy by left ventricular ejection fraction.左心室射血分数指导的心脏再同步化治疗的长期疗效。
Eur J Heart Fail. 2019 Mar;21(3):360-369. doi: 10.1002/ejhf.1357. Epub 2018 Dec 28.
4
Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.心脏再同步治疗后左心室逆重构对预后的影响存在显著差异,与心力衰竭的病因有关。
Heart Rhythm. 2018 Jan;15(1):130-136. doi: 10.1016/j.hrthm.2017.08.021. Epub 2017 Aug 24.
5
Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.心脏再同步治疗中完全左侧反向重构的临床意义:MADIT-CRT 子研究。
J Am Coll Cardiol. 2016 Sep 20;68(12):1268-76. doi: 10.1016/j.jacc.2016.06.051.
6
Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.QRS 波群持续时间和形态对心脏再同步治疗后左心室逆向重构和左心室功能改善的影响。
Eur J Heart Fail. 2017 Sep;19(9):1145-1151. doi: 10.1002/ejhf.769. Epub 2017 Feb 8.
7
Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?射血分数中度降低的心力衰竭患者的心脏再同步治疗:它会引发超级反应吗?
Indian Heart J. 2019 May-Jun;71(3):229-234. doi: 10.1016/j.ihj.2019.04.010. Epub 2019 May 3.
8
Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.左心室导线位置与心脏再同步治疗患者的长期预后
JACC Clin Electrophysiol. 2018 Nov;4(11):1410-1420. doi: 10.1016/j.jacep.2018.07.006. Epub 2018 Aug 29.
9
High Left Ventricular Lead Sensing Delay Predicts QRS Narrowing and Good Response to Cardiac Resynchronization Therapy.左心室高导联感知延迟可预测QRS波变窄及心脏再同步治疗的良好反应。
Pacing Clin Electrophysiol. 2016 Dec;39(12):1317-1326. doi: 10.1111/pace.12963. Epub 2016 Nov 10.
10
Left atrial reverse remodeling predicts long-term survival after cardiac resynchronization therapy.左心房逆向重构可预测心脏再同步化治疗后的长期生存。
J Echocardiogr. 2022 Jun;20(2):115-123. doi: 10.1007/s12574-021-00559-0. Epub 2021 Nov 25.

引用本文的文献

1
Impact of Angiotensin Receptor-Neprilysin Inhibitor Therapy on Cardiac Remodeling in Patients with Heart Failure and Reduced Ejection Fraction.血管紧张素受体-中性肽链内切酶抑制剂治疗对射血分数降低的心力衰竭患者心脏重塑的影响
J Cardiovasc Echogr. 2025 Jan-Mar;35(1):23-31. doi: 10.4103/jcecho.jcecho_58_24. Epub 2025 Apr 30.
2
Feasibility of CMR Imaging during Biventricular Pacing: Comparison with Invasive Measurement as a Pathway towards a Novel Optimization Strategy.双心室起搏期间心脏磁共振成像的可行性:与有创测量比较作为新型优化策略的途径
J Clin Med. 2023 Jun 12;12(12):3998. doi: 10.3390/jcm12123998.
3
Joint modelling of longitudinal processes and time-to-event outcomes in heart failure: systematic review and exemplar examining the relationship between serum digoxin levels and mortality.

本文引用的文献

1
Adverse Remodeling and Reverse Remodeling After Myocardial Infarction.心肌梗死后的不良重塑与逆向重塑
Curr Cardiol Rep. 2017 Aug;19(8):71. doi: 10.1007/s11886-017-0876-4.
2
Avoiding non-responders to cardiac resynchronization therapy: a practical guide.避免心脏再同步治疗无应答者:实用指南。
Eur Heart J. 2017 May 14;38(19):1463-1472. doi: 10.1093/eurheartj/ehw270.
3
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
心力衰竭纵向过程和生存时间结局的联合建模:系统评价和示例研究血清地高辛水平与死亡率的关系。
BMC Med Res Methodol. 2023 Apr 19;23(1):94. doi: 10.1186/s12874-023-01918-4.
4
Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential.心脏肥大在健康和疾病中的消退:机制和治疗潜力。
Nat Rev Cardiol. 2023 May;20(5):347-363. doi: 10.1038/s41569-022-00806-6. Epub 2023 Jan 4.
5
Utilization and Efficacy of Cardiac Resynchronization Therapy in Patients With Chronic Heart Failure - A Report From the CHART-2 Study.慢性心力衰竭患者心脏再同步治疗的应用与疗效——CHART-2研究报告
Circ Rep. 2022 May 25;4(6):264-273. doi: 10.1253/circrep.CR-22-0036. eCollection 2022 Jun 10.
2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
4
Long-Term Echocardiographic Response to Cardiac Resynchronization Therapy in Initial Nonresponders.初始无应答者心脏再同步治疗的长期超声心动图反应。
JACC Heart Fail. 2015 Dec;3(12):990-7. doi: 10.1016/j.jchf.2015.09.006. Epub 2015 Nov 11.
5
Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.与一级预防植入式心脏复律除颤器和心脏再同步治疗设备接受者的预后相关的随访左心室射血分数变化
J Am Coll Cardiol. 2015 Aug 4;66(5):524-31. doi: 10.1016/j.jacc.2015.05.057.
6
The war against heart failure: the Lancet lecture.与心力衰竭作斗争:柳叶刀演讲。
Lancet. 2015 Feb 28;385(9970):812-24. doi: 10.1016/S0140-6736(14)61889-4. Epub 2014 Nov 16.
7
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.一项针对五个随机试验的个体患者荟萃分析,评估心脏再同步治疗对有症状心力衰竭患者的发病率和死亡率的影响。
Eur Heart J. 2013 Dec;34(46):3547-56. doi: 10.1093/eurheartj/eht290. Epub 2013 Jul 29.
8
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).2013年欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗指南:欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗特别工作组。与欧洲心律协会(EHRA)合作制定。
Europace. 2013 Aug;15(8):1070-118. doi: 10.1093/europace/eut206. Epub 2013 Jun 24.
9
Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.心脏再同步治疗对轻度心力衰竭的长期影响:来自左心室收缩功能障碍再同步治疗逆转重构(REVERSE)研究的 5 年结果。
Eur Heart J. 2013 Sep;34(33):2592-9. doi: 10.1093/eurheartj/eht160. Epub 2013 May 2.
10
Cardiac-resynchronization therapy for mild-to-moderate heart failure.心脏再同步治疗轻中度心力衰竭。
N Engl J Med. 2010 Dec 16;363(25):2385-95. doi: 10.1056/NEJMoa1009540. Epub 2010 Nov 14.